Location of Repository

Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11

By Danny J. Schust, Domenico Tortorella, Jörg Seebach, Cindy Phan and Hidde L. Ploegh

Abstract

US11 and US2 encode gene products expressed early in the replicative cycle of human cytomegalovirus (HCMV), which cause dislocation of human and murine major histocompatibility complex (MHC) class I molecules from the lumen of the endoplasmic reticulum to the cytosol, where the class I heavy chains are rapidly degraded. Human histocompatibility leukocyte antigens (HLA)-C and HLA-G are uniquely resistant to the effects of both US11 and US2 in a human trophoblast cell line as well as in porcine endothelial cells stably transfected with human class I genes. Dislocation and degradation of MHC class I heavy chains do not appear to involve cell type–specific factors, as US11 and US2 are fully active in this xenogeneic model. Importantly, trophoblasts HLA-G and HLA-C possess unique characteristics that allow their escape from HCMV-associated MHC class I degradation. Trophoblast class I molecules could serve not only to block recognition by natural killer cells, but also to guide virus-specific HLA-C– and possibly HLA-G–restricted cytotoxic T-lymphocytes to their targets

Topics: Articles
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2212475
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1990). A class I antigen, HLA-G, expressed in human trophoblasts.
    2. (1997). A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.
    3. (1995). A viral inhibitor of peptide transporters for antigen presentation.
    4. (1991). Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization.
    5. (1984). Class I major histocompatibility complex antigens on human extravillous cytotrophoblast.
    6. (1970). Cytomegalovirus isolations associated with pregnancy wastage.
    7. (1996). Derivation of immortalized swine stromal cell lines.
    8. (1990). Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcioma cell lines.
    9. (1992). Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.
    10. (1997). Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens.
    11. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line.
    12. (1993). Evidence for a polymorphism of HLA-G gene.
    13. (1996). Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast.
    14. Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res.
    15. (1996). Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-g.
    16. (1995). Getting the inside out: The transporter associated with antigen processing (TAP) and the presentation of viral antigen.
    17. (1996). Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells.
    18. (1995). Herpes simplex virus turns off the TAP to evade host immunity.
    19. (1992). HLA and maternal-fetal recognition.
    20. (1997). HLA class I expression on the materno-fetal interface.
    21. (1997). HLA-Cw3 expression on porcine endothelial cells protects against xenogenic cytotoxicity mediated by a subset of human NK cells.
    22. (1997). HLA-G functions as a restriction element and a transplantation antigen in mice.
    23. (1996). HLA-G gene polymorphism in a Japanese population.
    24. (1997). HLA-G gene polymorphism segregation within CEPH reference families.
    25. (1994). HLA-G polymorphisms in African Americans.
    26. (1993). Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains.
    27. (1996). Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
    28. (1996). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
    29. (1990). Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule.
    30. (1990). Human trophoblast cells in culture express an unusual major histocompatibility complex class I-like antigen.
    31. (1986). Immunity to cytomegalovirus in women with unexplained recurrent spontaneous abortion.
    32. (1974). Immunologic competence of the immature human fetus: morphologic evidence from intrauterine cytomegalovirus infection.
    33. (1993). In situ hybridization and Northern blot demonstration of HLA-G mRNA in human trophoblast populations by locus-specific oligonucleotides.
    34. (1997). In vitro translation and assembly of a complete T cell receptor-CD3 complex.
    35. (1987). Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects.
    36. (1995). Low HLA-C expression at the cell surfaces correlates with increased turnover of heavy chain mRNA.
    37. (1986). Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.
    38. (1995). Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of human major histocompatibility complex class I heavy chains.
    39. (1989). Novel human MHC class I genes are expressed by tumor cell lines representing embryonic and extraembryonic tissues.
    40. (1978). Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens—new tools for genetic analysis.
    41. (1996). Protection from natural killer cell-mediated lysis by HLA-G expression on target cells.
    42. (1996). Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.
    43. (1997). The a1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    44. (1996). The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine MHC class I heavy chains.
    45. (1994). The HLA-G gene is expressed at a low mRNA level in different human cells and tissues.
    46. (1996). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.
    47. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.
    48. (1995). The membranebound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
    49. (1990). The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acid Res.
    50. (1993). Three new HLA-G alleles and their linkage disequilibria with HLA-A.
    51. (1979). Use of monoclonal antibody (W6/32) in structural studies of HLA-A,
    52. (1998). Viral strategies of immune evasion.
    53. (1998). Why HLA-G and HLA-A cross-react: Epitope mapping of two common anti-MHC class I antibodies.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.